bavdegalutamide,abiraterone
janssen,arvinas
['abiraterone', 'bavdegalutamide', 'prostate']
phase 1b study of bavdegalutamide, an androgen receptor protac degrader, combined with abiraterone in patients with metastatic #prostatecancer. presented by neal shore, md, facs . #asco22 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology